Literature DB >> 35039989

Neurological manifestation of 22q11.2 deletion syndrome.

Michael Bayat1, Allan Bayat2.   

Abstract

22q11.2 deletion syndrome is the most common microdeletion syndrome. This article reviews the different neurological manifestations of 22q11.2 deletion syndrome. The syndrome is associated with neurological disorders such as epilepsy and movement disorders. Patients with 22q11.2 DS have an increased incidence of provoked and unprovoked seizures. Provoked seizures include, amongst others, seizures due to hypocalcemia, surgery, perioperative hypoxia, antipsychotic medication, and fever. Both focal seizures, myoclonus and generalized tonic-clonic seizures occur in 22q11.2 DS. Generalized epilepsy occurs more often than in the background population. Furthermore, 22q11.2 DS is associated with a significantly increased risk of developing Parkinson's disease, and an increased incidence of dystonia has also been suggested. Abnormal neuroradiological findings - amongst them polymicrogyria - are common in 22q11.2.2 DS and reviewed in the article. The risk of psychiatric disorders, in particular schizophrenia, is increased in 22q11.2 DS.
© 2021. Fondazione Società Italiana di Neurologia.

Entities:  

Keywords:  22q11.2 deletion syndrome; DiGeorge syndrome; Epilepsy; Movement disorders; Parkinson’s disease

Mesh:

Substances:

Year:  2022        PMID: 35039989     DOI: 10.1007/s10072-021-05825-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  26 in total

1.  Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications.

Authors:  Nancy J Butcher; Tim-Rasmus Kiehl; Lili-Naz Hazrati; Eva W C Chow; Ekaterina Rogaeva; Anthony E Lang; Anne S Bassett
Journal:  JAMA Neurol       Date:  2013-11       Impact factor: 18.302

2.  Response to clozapine in a clinically identifiable subtype of schizophrenia.

Authors:  Nancy J Butcher; Wai Lun Alan Fung; Laura Fitzpatrick; Alina Guna; Danielle M Andrade; Anthony E Lang; Eva W C Chow; Anne S Bassett
Journal:  Br J Psychiatry       Date:  2015-03-05       Impact factor: 9.319

3.  Polymicrogyria and deletion 22q11.2 syndrome: window to the etiology of a common cortical malformation.

Authors:  Nathaniel H Robin; Clare J Taylor; Donna M McDonald-McGinn; Elaine H Zackai; Peter Bingham; Kevin J Collins; Dawn Earl; Deepak Gill; Tiziana Granata; Renzo Guerrini; Naomi Katz; Virginia Kimonis; Jean-Pierre Lin; David R Lynch; Shehla N Mohammed; Roger F Massey; Marie McDonald; R Curtis Rogers; Miranda Splitt; Cathy A Stevens; Marc D Tischkowitz; Neil Stoodley; Richard J Leventer; Daniela T Pilz; William B Dobyns
Journal:  Am J Med Genet A       Date:  2006-11-15       Impact factor: 2.802

4.  Generalized Epilepsy and Myoclonic Seizures in 22q11.2 Deletion Syndrome.

Authors:  Vincent Strehlow; Marielle E M Swinkels; Rhys H Thomas; Nora Rapps; Steffen Syrbe; Thomas Dorn; Johannes R Lemke
Journal:  Mol Syndromol       Date:  2016-08-24

5.  Increased prevalence of unprovoked seizures in patients with a 22q11.2 deletion.

Authors:  Amy Kao; Juliana Mariani; Donna M McDonald-McGinn; Melissa K Maisenbacher; Amy R Brooks-Kayal; Elaine H Zackai; David R Lynch
Journal:  Am J Med Genet A       Date:  2004-08-15       Impact factor: 2.802

6.  Myoclonic epilepsy, parkinsonism, schizophrenia and left-handedness as common neuropsychiatric features in 22q11.2 deletion syndrome.

Authors:  Martina Fanella; Marianna Frascarelli; Caterina Lambiase; Alessandra Morano; Marta Unolt; Natascia Liberati; Jinane Fattouch; Antonino Buzzanca; Tommaso Accinni; Marco Ceccanti; Alessandro Viganò; Massimo Biondi; Claudio Colonnese; Anna Teresa Giallonardo; Fabio Di Fabio; Antonio Pizzuti; Carlo Di Bonaventura; Alfredo Berardelli
Journal:  J Med Genet       Date:  2019-09-10       Impact factor: 6.318

Review 7.  Epilepsy in 22q11.2 Deletion Syndrome: A Case Series and Literature Review.

Authors:  Basanagoud Mudigoudar; Sunitha Nune; Stephen Fulton; Ehab Dayyat; James W Wheless
Journal:  Pediatr Neurol       Date:  2017-08-26       Impact factor: 3.372

8.  Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study.

Authors:  A K Ryan; J A Goodship; D I Wilson; N Philip; A Levy; H Seidel; S Schuffenhauer; H Oechsler; B Belohradsky; M Prieur; A Aurias; F L Raymond; J Clayton-Smith; E Hatchwell; C McKeown; F A Beemer; B Dallapiccola; G Novelli; J A Hurst; J Ignatius; A J Green; R M Winter; L Brueton; K Brøndum-Nielsen; P J Scambler
Journal:  J Med Genet       Date:  1997-10       Impact factor: 6.318

9.  Epilepsy and Other Neuropsychiatric Manifestations in Children and Adolescents with 22q11.2 Deletion Syndrome.

Authors:  Eun Hee Kim; Mi Sun Yum; Beom Hee Lee; Hyo Won Kim; Hyun Jeoung Lee; Gu Hwan Kim; Yun Jeong Lee; Han Wook Yoo; Tae Sung Ko
Journal:  J Clin Neurol       Date:  2016-01       Impact factor: 3.077

10.  Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2.

Authors:  Erik Boot; Nancy J Butcher; Sean Udow; Connie Marras; Kin Y Mok; Satoshi Kaneko; Matthew J Barrett; Paolo Prontera; Brian D Berman; Mario Masellis; Boris Dufournet; Karine Nguyen; Perrine Charles; Eugénie Mutez; Teodor Danaila; Aurélia Jacquette; Olivier Colin; Sophie Drapier; Michel Borg; Ania M Fiksinski; Elfi Vergaelen; Ann Swillen; Annick Vogels; Annika Plate; Claudia Perandones; Thomas Gasser; Kristien Clerinx; Frédéric Bourdain; Kelly Mills; Nigel M Williams; Nicholas W Wood; Jan Booij; Anthony E Lang; Anne S Bassett
Journal:  Neurology       Date:  2018-05-11       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.